Results 91 to 100 of about 13,013 (192)
KMT2D, SETD2 and SETD1A mutational signature and clinical outcome.
A. Association of KMT2D, SETD2, and SETD1A mutational signature with patient outcome in all breast tumors. B. Association of KMT2D and SETD2 mutational signatures with prognosis in triple negative breast tumors.
Alberto Ocana (2697079) +9 more
core +1 more source
CRISPR-Cas9 mediated Kdm6a and Kmt2d KO BV2 cells.
(A) Sequence alignment of two Kdm6a KO clones in BV2 cells with 2 bp and 1 bp nucleotide deletion, respectively. (B) Sequence alignment of two Kmt2d KO clones in BV2 cells with 7 bp and 2 bp nucleotide deletion, respectively. (TIF)
Scott B. Biering (7165010) +15 more
core +1 more source
Abstract Background Myocyte enhancer factor 2 transcription factors regulate essential transcriptional programs in various cell types. The activity of myocyte enhancer factor 2 factors is modulated through interactions with cofactors, chromatin remodelers, and other regulatory proteins, which are dependent on cell context and physiological state.
Karine de Mattos +4 more
wiley +1 more source
ObjectiveTo explore the clinical characteristics of patients with diffuse large B-cell lymphoma (DLBCL) accompanied with KMT2D gene mutation and the impact of its co-mutated genes on prognosis.
Mutibaier·MIJITI +10 more
doaj +1 more source
Uncovering the Genetic Landscape of Pediatric Hearing Loss Along the Texas–Mexico Border
Project GIVE provided evaluations and genome sequencing to 23 children with hearing loss along the Texas–Mexico border. Seventy percent received a molecular diagnosis and 56% of those diagnosed had changes to medical management. In this region, underdiagnosis of genetic hearing loss is due to care barriers rather than lower genetic burden.
Desiree Lanehart +17 more
wiley +1 more source
Kmt2c and Kmt2d histone methyltransferase deficiencies compromise macrophage function
Abstract Methylation of histone (H) 3 lysine (K) 4 (H3K4) has a well-established role in innate immune responses, but the contribution of H3K4 methyltransferases Kmt2c and Kmt2d in innate immunity is incompletely understood. Using conditional knockout mouse models, we investigated how Kmt2c- and Kmt2d-deficiencies affect innate immune
Burcu Al +13 more
openaire +3 more sources
[Supplementary Figure 1] Schematic of exon-intron structure of KMT2B in chromosome 19 and KMT2D transcript in chromosome 12 (GRCh37/hg19) [Supplementary Figure 2] DMPs showing significant GOM (gain of methylation) or LOM (loss of methylation) in DYT ...
Siddharth Banka (8432901) +11 more
core +1 more source
KMT2C and KMT2D amplify GRHL2-driven enhancer activation
Abstract The activation of cis-regulatory enhancers is essential for cell fate specification by driving cell type-specific gene expression. Differentiation models are widely used to study enhancer biology but the asynchronous and interdependent nature of gene regulatory changes during cell state transitions can complicate mechanistic ...
Ryan M. Boileau +2 more
openaire +2 more sources
Background Kabuki syndrome (KS) is a rare pediatric congenital disorder with multiple congenital anomalies and intellectual disabilities, which is inherited in an autosomal dominant manner.
Chengqi Xin +6 more
doaj +1 more source
Additional file 2: Figure S2. A Immunoblotting and quantification analysis of cancer stem cells markers including CD133, OCT4, ALDH1A1 in SCC4, SCC25, and CAL27 cells transfected with Sh-CON and Sh-KMT2D.
Shaopeng Liu (411451) +8 more
core +1 more source

